Middle East Pharmaceutical Industries Co. announces the opening of the nomination period for the board of director’s membership for next term.

The nomination for membership on the Board of Directors for the next term will be in accordance with the provisions outlined in the Companies Law, the Corporate Governance Regulations issued by the Capital Market Authority, and the Company’s Board of Directors’ Membership Policies and Standards (attached), which have been approved by the General Assembly.

The selection of the nominated members for the new term will take place at the General Assembly Meeting, which will be announced later after obtaining the necessary regulatory approvals from the competent authorities.

Nomination applications, including all attachments and the forms, shall be sent to the email address below:

nrc@avalon.com.sa

We are pleased to receive your inquiries or comments by contacting our Investor Relations Department through:

Tel: (+966) 118365000 - 3374

E-mail: investor.relations@avalon.com.sa

Considering the Company’s Board of Directors’ Membership Policies and Standards, which have been approved by the General Assembly (Attached).

Second: Nomination requirements:

To ensure the acceptance of the nomination application, all the Company’s requirements and standards for nomination must be fulfilled, and all required attachments and forms must be completed electronically, as referred to in the Company’s Board of Directors’ Membership Policies and Standards. These forms must be submitted in Arabic or English.